Management of venous thromboembolism and the potential to impact overall survival in patients with cancer.

about

Saddle pulmonary embolism in a cancer patient with thrombocytopenia: a treatment dilemma.Role of factor xa inhibitors in cancer-associated thrombosis: any new data?

P2860

Q33393653-4E7CD840-AFFC-4637-864C-FEE449A9D0E6 Q34052232-E2ED4181-C418-460D-8F98-28AC84FDBF87

P2860

Management of venous thromboembolism and the potential to impact overall survival in patients with cancer.

Item

http://www.wikidata.org/entity/Q37621554

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Management of venous thromboem ...... vival in patients with cancer.

@en

Management of venous thromboem ...... vival in patients with cancer.

@nl

type

Item

label

Management of venous thromboem ...... vival in patients with cancer.

@en

Management of venous thromboem ...... vival in patients with cancer.

@nl

prefLabel

Management of venous thromboem ...... vival in patients with cancer.

@en

Management of venous thromboem ...... vival in patients with cancer.

@nl

P1476

Management of venous thromboem ...... vival in patients with cancer.

@en

P2093

Biren Saraiya

http://www.w3.org/2001/XMLSchema#string

Susan Goodin

http://www.w3.org/2001/XMLSchema#string

P2860

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

Efficacy and safety of epoetin alfa in critically ill patients

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group

Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data.

Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy.

Low-molecular-weight heparins : mechanisms, trials, and role in contemporary interventional medicine.

P304

1344-1356

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1592/PHCO.29.11.1344

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2009-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19857150

http://www.w3.org/2001/XMLSchema#string

P921

venous thromboembolism

Management of venous thromboembolism and the potential to impact overall survival in patients with cancer.

about

P2860

P2860

Management of venous thromboembolism and the potential to impact overall survival in patients with cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921